|
Differences between patients with thalamic haemorrhage and patients with internal capsule-basal ganglia haemorrhage |
|||
| Data |
Thalamic haemorrhage |
Internal capsule-basal ganglia haemorrhage |
P value |
|
|
|||
| Total patients |
47 |
77 |
|
| Sex, male |
27 (57.4) |
50 (64.9) |
0.259 |
| Age, years, mean (SD) |
71.6 (10.9) |
72.2 (12.2) |
0.661 |
| Vascular risk factors |
|||
| Hypertension |
29 (61.7) |
57 (74) |
0.107 |
| Diabetes mellitus |
8 (17) |
9 (11.7) |
0.282 |
| Dyslipemia |
7 (14.9) |
10 (13) |
0.481 |
| Atrial fibrillation |
5 (10.6) |
11 (14.3) |
0.384 |
| Ischaemic heart disease |
3 (6.4) |
5 (6.5) |
0.646 |
| Cigarette smoking (> 20/day) |
3 (6.4) |
8 (10.4) |
0.339 |
| Chronic liver disease |
5 (10.6) |
0 |
0.007 |
| Clinical findings |
|||
| Sudden onset (min) |
35 (74.5) |
48 (52.3) |
0.115 |
| Limb weakness |
37 (78.7) |
67 (87) |
0.167 |
| Sensory symptoms |
33 (70.2) |
38 (49.4) |
0.018 |
| Altered consciousness |
15 (31.9) |
23 (29.9) |
0.482 |
| Headache |
14 (29.8) |
18 (23.4) |
0.279 |
| Nausea, vomiting |
13 (27.7) |
10 (13) |
0.037 |
| Speech disturbances (dysarthria, aphasia) |
10 (21.3) |
34 (44.2) |
0.008 |
| Ataxia |
4 (8.5) |
0 |
0.019 |
| Lacunar syndrome |
4 (8.5) |
18 (23.4) |
0.036 |
| Ventricular involvement |
20 (42.6) |
12 (15.6) |
0.001 |
| Outcome |
|||
| In-hospital mortality |
9 (19.1) |
13 (16.9) |
0.464 |
| Respiratory complications |
8 (17) |
8 (10.4) |
0.212 |
| Urinary complications |
8 (17) |
7 (9.1) |
0.152 |
| Infectious complications |
16 (34) |
17 (22.1) |
0.106 |
| Symptom-free at discharge |
1 (2.1) |
6 (7.8) |
0.180 |
|
Data are n (%) unless otherwise stated. | |||
Arboix et al. BMC Neurology 2007 7:32 doi:10.1186/1471-2377-7-32 |
|||